305 related articles for article (PubMed ID: 33576497)
61. Ocular surface disease associated with dupilumab treatment for atopic diseases.
Utine CA; Li G; Asbell P; Pflugfelder S; Akpek E
Ocul Surf; 2021 Jan; 19():151-156. PubMed ID: 32439390
[TBL] [Abstract][Full Text] [Related]
62. Rosacea associated with dupilumab therapy.
Heibel HD; Hendricks AJ; Foshee JP; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
[No Abstract] [Full Text] [Related]
63. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study.
Deleuran M; Thaçi D; Beck LA; de Bruin-Weller M; Blauvelt A; Forman S; Bissonnette R; Reich K; Soong W; Hussain I; Foley P; Hide M; Bouaziz JD; Gelfand JM; Sher L; Schuttelaar MLA; Wang C; Chen Z; Akinlade B; Gadkari A; Eckert L; Davis JD; Rajadhyaksha M; Staudinger H; Graham NMH; Pirozzi G; Ardeleanu M
J Am Acad Dermatol; 2020 Feb; 82(2):377-388. PubMed ID: 31374300
[TBL] [Abstract][Full Text] [Related]
64. Successful treatment of recurrent exit site and tunnel infections caused by atopic dermatitis with dupilumab: A case report.
Noda R; Ishibashi Y
Ther Apher Dial; 2022 Feb; 26(1):255-256. PubMed ID: 34018694
[No Abstract] [Full Text] [Related]
65. Ulcerative colitis during dupilumab therapy in a patient with atopic dermatitis.
Seishima M; Sasaki M; Hachiken H; Furukawa T; Yagi N; Sugie S
J Dermatol; 2023 Dec; 50(12):e420-e421. PubMed ID: 37622193
[No Abstract] [Full Text] [Related]
66. Severe atopic dermatitis: Dupilumab is not just safer, but more efficient.
Giavina-Bianchi M; Rizzo LV; Giavina-Bianchi P
Allergol Immunopathol (Madr); 2020; 48(6):792-797. PubMed ID: 32249095
[TBL] [Abstract][Full Text] [Related]
67. Herpes simplex virus encephalitis in atopic dermatitis patients and responses to dupilumab: A real association or a chance occurrence?
Shi JQ; Dong XS; Zhang LL; Liu ZH
Pediatr Dermatol; 2022 Sep; 39(5):848-849. PubMed ID: 36206220
[No Abstract] [Full Text] [Related]
68.
Doolan BJ; Yeon J; Baker DA; Whitfeld MJ
AIDS Res Hum Retroviruses; 2022 Feb; 38(2):76-79. PubMed ID: 34384267
[No Abstract] [Full Text] [Related]
69. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
[TBL] [Abstract][Full Text] [Related]
70. Dupixent® (Dupilumab): A Newly Approved Interleukin-4 Receptor Antagonist for the Treatment of Atopic Dermatitis in Pediatric Patients.
Gupta AK; Love RP; Abramovits W; Vincent KD
Skinmed; 2019; 17(2):107-109. PubMed ID: 31145061
[No Abstract] [Full Text] [Related]
71. Alopecia Universalis and Atopic Dermatitis Improvement with Dupilumab: Demonstration of a Shared Pathophysiology and Clinical Efficacy.
Dobkin H; Mullen R; Zirwas M
Skinmed; 2019; 17(2):139-140. PubMed ID: 31145072
[No Abstract] [Full Text] [Related]
72. Atopic Dermatitis Patient With Hepatitis C Treated With Dupilumab-A Case Report.
Mota F
Actas Dermosifiliogr; 2024 Apr; 115(4):T420-T421. PubMed ID: 38325544
[No Abstract] [Full Text] [Related]
73. Atopic Dermatitis Patient With Hepatitis C Treated With Dupilumab-A Case Report.
Mota F
Actas Dermosifiliogr; 2024 Apr; 115(4):420-421. PubMed ID: 37290670
[No Abstract] [Full Text] [Related]
74. Improved sleep in adults with atopic dermatitis using the treatment dupilumab.
Br J Dermatol; 2023 Nov; 189(6):e106. PubMed ID: 37972138
[No Abstract] [Full Text] [Related]
75. Treatment of children from 6 to 11 years old affected by moderate-severe atopic dermatitis with dupilumab: a first perspective from a single-center real-life experience in Italy.
Colonna C; Zussino M; Monzani NA; Ponziani A; Cavalli R
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e478-e480. PubMed ID: 35067995
[No Abstract] [Full Text] [Related]
76. Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis.
Achten R; Bakker D; Ariens L; Lans A; Thijs J; van der Schaft J; de Boer J; Balak D; de Graaf M; van Luijk C; de Bruin-Weller M
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1389-1392.e2. PubMed ID: 33038589
[No Abstract] [Full Text] [Related]
77. Dupilumab for the treatment of adolescents with atopic dermatitis.
Senner S; Seegräber M; Frey S; Kendziora B; Eicher L; Wollenberg A
Expert Rev Clin Immunol; 2020 Jul; 16(7):641-650. PubMed ID: 32720530
[TBL] [Abstract][Full Text] [Related]
78. Psoriasis-like Dermatitis Developing in a Patient with Atopic Dermatitis Treated with Dupilumab.
Stout M; Guitart J; Tan T; Silverberg JI
Dermatitis; 2019; 30(6):376-378. PubMed ID: 31609853
[No Abstract] [Full Text] [Related]
79. Atopic dermatitis treated safely with dupilumab during pregnancy and lactation: A case series of four patients.
Hong N; Park SY; Kook HD; Lee DH; Jung HJ; Park MY; Ahn J
Australas J Dermatol; 2024 Jun; 65(4):e100-e103. PubMed ID: 38509808
[No Abstract] [Full Text] [Related]
80. A detailed evaluation of the effect of dupilumab on sleep in adults with atopic dermatitis.
Lee EY; Drucker AM
Br J Dermatol; 2023 Nov; 189(6):649-655. PubMed ID: 37658831
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
